Your browser doesn't support javascript.
loading
Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old.
Fitz-Patrick, David; Young, Mariano; Yacisin, Kari; McElwee, Kathleen; Belanger, Todd; Belanger, Kelly; Peng, Yahong; Lee, Dung-Yang; Gruber, William C; Scott, Daniel A; Watson, Wendy.
Affiliation
  • Fitz-Patrick D; East-West Medical Research Institute, Honolulu, HI, USA.
  • Young M; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA. Electronic address: Mariano.Young-Jr@pfizer.com.
  • Yacisin K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • McElwee K; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
  • Belanger T; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Belanger K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Peng Y; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
  • Lee DY; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
  • Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
  • Scott DA; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
  • Watson W; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Vaccine ; 41(28): 4190-4198, 2023 06 23.
Article in En | MEDLINE | ID: mdl-37244809
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pneumococcal Infections / COVID-19 Vaccines / COVID-19 Type of study: Clinical_trials Limits: Aged / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pneumococcal Infections / COVID-19 Vaccines / COVID-19 Type of study: Clinical_trials Limits: Aged / Humans Language: En Year: 2023 Type: Article